K2 Principal Fund’s Orthofix Medical OFIX Stock Holding History

K2 Principal Fund’s Portfolio OFIX Stock Details OFIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-31,780	Closed	-$652K	–	299
2022 Q4	$652K	Buy	+31,780	New	+$561K	0.1%	120

Other funds holding OFIX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

K2 Principal Fund's OFIX Position: Q1 2023 in Review

K2 Principal Fund sold out of Orthofix Medical (OFIX) in Q1 2023, closing a stake of 31,780 shares — an estimated $652K sold.

K2 Principal Fund first reported a position in OFIX in Q4 2022 and held it in 1 quarter. The position peaked at $652K in Q4 2022. 162 funds tracked by Wall St. Rank hold OFIX as of Q1 2023.

K2 Principal Fund reported no remaining Orthofix Medical position as of Q1 2023 after selling out during the quarter.
K2 Principal Fund sold 31,780 Orthofix Medical shares in Q1 2023, an estimated $652K.
K2 Principal Fund first reported a position in Orthofix Medical in Q4 2022 and held it in 1 quarter.
K2 Principal Fund's Orthofix Medical position peaked at $652K in Q4 2022.
162 funds tracked by Wall St. Rank held Orthofix Medical as of Q1 2023.

Based on K2 Principal Fund's 13F filing for Q1 2023, filed 11 May 2023.